Spica is pioneering therapies based on macrophage biology. Its proprietary fingerprinting technology identifies disease-driving macrophage subsets, enabling first-in-class depletion strategies in oncology and fibroinflammatory diseases.
Location: Antwerp, Belgium and Aarhus, Denmark
Board director: Alexander Demoulin - Debora Dumont
Website: